Axcella to Present at the SVB Leerink 9th Annual Global Healthcare Conference
February 19 2020 - 8:00AM
Business Wire
Presentation and webcast to take place at 9:00
a.m. ET on February 26
Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company
focused on leveraging endogenous metabolic modulators (EMMs) to
pioneer a new approach for treating complex diseases and improving
health, today announced that management will be presenting at the
SVB Leerink 9th Annual Global Healthcare Conference in New York
City on February 26, 2020 at 9:00 a.m. ET.
A live audio webcast of the presentation will be available on
the “Investors & News” section of the company’s website,
www.axcellahealth.com. A replay will also be available on Axcella’s
website for 30 days following the presentation.
Internet Posting of Information
Axcella uses its website, www.axcellahealth.com, as a means of
disclosing material nonpublic information and for complying with
its disclosure obligations under Regulation FD. Such disclosures
will be included on the company’s website in the “Investors and
News” section. Accordingly, investors should monitor such portions
of the company’s website, in addition to following its press
releases, SEC filings and public conference calls and webcasts.
About Axcella
Axcella is a clinical-stage biotechnology company focused on
leveraging endogenous metabolic modulators (EMMs) to pioneer a new
approach for treating complex diseases and improving health. The
company’s product candidates are comprised of EMMs and their
derivatives that are engineered in distinct combinations and ratios
to simultaneously impact multiple biological pathways. Axcella’s
pipeline includes lead therapeutic candidates for non-alcoholic
steatohepatitis (NASH) and the prevention of recurrent overt
hepatic encephalopathy (OHE). Additional muscle- and blood-related
programs are in earlier-stage development. For more information,
please visit www.axcellahealth.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200219005040/en/
Investor Contact Jason Fredette
jfredette@axcellahealth.com 857.320.2236
Media Contact Azeem Zeekrya HDMZ azeem.zeekrya@hdmz.com
312-506-5244
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Axcella Health (NASDAQ:AXLA)
Historical Stock Chart
From Apr 2023 to Apr 2024